Pipeline

PAT205/206

PAT205/206
Program PAT205/206
Active Substance Triple Agonist-Albumin Conjugate
Disease Obesity
Development stage Optimization

A triple G peptide-albumin conjugate that provides significant weight loss and
a longer half-life compared to other competitors.

PAT205/206 MOA

  • GLP-1/GCG Agonist

    GLP-1/GCG Agonist

    Weight loss Increased metabolic rate Blood glucose regulation Cholesterol management

  • GLP-1/GIP Agonist

    GLP-1/GIP Agonist

    Weight loss blood glucose regulation Promotion of fat breakdown Cholesterol management

  • GLP-1/GIP/GCG Agonist

    GLP-1/GIP/GCG Agonist

    Weight loss blood glucose regulation Reverse fatty liver Promotion of fat breakdown Increased metabolic rate Cholesterol management

PAT205/206 is a long-acting peptide conjugate that can be administered
once every two weeks, leading to significant weight loss.

KOR